Page last updated: 2024-11-05

3,5-dimethylpyrazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,5-dimethylpyrazole: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6210
CHEMBL ID1828957
MeSH IDM0089656

Synonyms (59)

Synonym
BB 0258795
3,5-dimethyl-1h-pyrazol
pyrazole, 3,5-dimethyl-
1h-pyrazole, 3,5-dimethyl-
3,5-dimethyl-1h-pyrazole
AE-848/32586026
nsc 8729
3,5-dwumetylopirazolu [polish]
brn 0106325
einecs 200-657-5
1h-pyrazole,5-dimethyl-
pyrazole,5-dimethyl-
3,5-dimethylpyrazole
nsc-8729
u 6245
th 564
nsc8729
3,5 dmp
67-51-6
STK299969
3,5-dimethylpyrazole, 99%
inchi=1/c5h8n2/c1-4-3-5(2)7-6-4/h3h,1-2h3,(h,6,7)
sdxawljrermrkf-uhfffaoysa-
D1647
AKOS000120332
QSPL 007
1(h)-3,5-dimethylpyrazole;1h-pyrazole,3,5-dimethyl-;3,5-dimethyl-1h-pyrazol
A22892
dimethylpyrazole
3,5-dimethyl-pyrazole
CHEMBL1828957
3,5-dwumetylopirazolu
ec 200-657-5
5-23-05-00110 (beilstein handbook reference)
h21n865k9j ,
unii-h21n865k9j
FT-0614706
AB00374449-03
AS-5542
3,5-dimethyl pyrazole
DTXSID5058777
1(h)-3,5-dimethylpyrazole
W-104711
th-564
u-6245
trixene dp 8692
mfcd00005243
F1982-0002
3,5-dimethylpyrazole, produced by wacker chemie ag, burghausen, germany, >=99.0% (gc)
P19711
Z50145988
SY001302
Q17122069
SB16017
3,5-dimethyl-1h-pyrazole;1h-pyrazole, 3,5-dimethyl-
BCP32182
AMY40839
NCGC00342010-01
EN300-16235

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" It is concluded that the age-related changes in mtDNA and function are likely to be the consequence of a failure of macroautophagy in the recognition and disposal of a small number of severely injured mitochondria, and that easy and safe ways are available to counteract this change."( Stimulation of macroautophagy can rescue older cells from 8-OHdG mtDNA accumulation: a safe and easy way to meet goals in the SENS agenda.
Bergamini, E; Cavallini, G; Donati, A; Taddei, M, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID728444Binding affinity to Enterobacteria phage T4 lysozyme L99A/M102H double mutant expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 1 mM at pH 5.4 by circular dichroism analysis2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
AID728443Binding affinity to Enterobacteria phage T4 lysozyme harboring L99A/M102H double mutant expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 1 mM at pH 6.8 by circular dichroism analysis2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
AID618366Antifungal activity against Saccharomyces cerevisiae BY4741 assessed as reduction in cell growth at 1 mM2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
New azole antifungal agents with novel modes of action: synthesis and biological studies of new tridentate ligands based on pyrazole and triazole.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (23.68)18.7374
1990's5 (13.16)18.2507
2000's8 (21.05)29.6817
2010's14 (36.84)24.3611
2020's2 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.72 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index54.52 (26.88)
Search Engine Supply Index1.97 (0.95)

This Compound (39.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]